IFNα Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment.
Hu B, Yu M, Ma X, Sun J, Liu C, Wang C, Wu S, Fu P, Yang Z, He Y, Zhu Y, Huang C, Yang X, Shi Y, Qiu S, Sun H, Zhu AX, Zhou J, Xu Y, Zhu D, Fan J.
Hu B, et al. Among authors: zhu d, zhu y, zhu ax.
Cancer Discov. 2022 Jul 6;12(7):1718-1741. doi: 10.1158/2159-8290.CD-21-1022.
Cancer Discov. 2022.
PMID: 35412588